Ribociclib Succinate (CAS 1374639-75-4)
« Back to Anti-Cancer API
Ribociclib Succinate
CAS No. 1374639-75-4
琥珀酸瑞波西利
Chemical structure
| CAS No. | 1374639-75-4 |
|---|---|
| Synonyms | 7-Cyclopentyl-N,N-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide succinate |
| Category | Anti-Cancer API / Anti-Cancer |
| Assay / Purity | 99% |
| Molecular Formula | C27H36N8O5 |
| Molecular Weight | 552.6 |
| Melting Point | — |
| Boiling Point | — |
| Density | — |
| Flash Point | — |
| Appearance | Light yellow to yellowish brown crystalline powder |
Application and positioning
Ribociclib succinate is a selective CDK4/6 inhibitor that arrests the cell cycle at the G1/S checkpoint, supplied as the succinate salt. It is used in oral tablets for HR-positive, HER2-negative advanced or metastatic breast cancer, in combination with endocrine therapy. Laurand supplies it from audited Chinese production partners for pharmaceutical manufacturing and process development.
Quality and documentation
- Batch-specific Certificate of Analysis issued by the manufacturing site
- SDS/MSDS and specification sheet available on request
- Residual solvents and elemental impurities statements discussed per project
- For pharmaceutical manufacturing and R&D use only — not for direct administration
Packaging and handling
- Packed in double polyethylene-lined fibre drums; pack size confirmed at quotation
- Small quantities in sealed aluminium foil bags
- Palletised for air and sea freight; store dry, ventilated and protected from light
Related products
- Temozolomide (CAS 85622-93-1)
- Vandetanib (CAS 443913-73-3)
- Veliparib (CAS 912444-00-9)
- Veliparib dihydrochloride (CAS 912445-05-7)
Specifications shown are indicative. The final specification and documentation package are confirmed with the quotation.
Interested in this product?
Contact us for price, COA, MSDS and lead time — custom synthesis available.
Request a QuoteReference: CAS 1374639-75-4 · PubChem CID 57334219